Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Hibiscus anthocyanins help protect the liver and improve antioxidants in diabetic rats.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Nilotinib can cause skin issues like red bumps and hair loss.

Social media can help compare the effectiveness and safety of new arthritis medications.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

A new treatment for hair loss shows promise with fewer side effects.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Rivaroxaban may cause hair loss.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.